Alexion to Discuss Key Pipeline Programs at Virtual Investor Day

BOSTON--(BUSINESS WIRE)--Sep. 14, 2020-- Alexion Pharmaceuticals (Nasdaq:ALXN) a biotechnology company focused in rare disease development and commercialization, today announced that the company will host a Virtual Investor Day on Tuesday, October 6th, 2020 from 8:00 a.m. to 12:00 p.m. ET. Management will highlight continued strategic advancement, including key pipeline opportunities and drivers of future growth.

An audio webcast of the presentation will be available live. More details will be available at http://ir.alexion.com leading up to the event. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.

[ALXN-G]

View source version on businesswire.com: https://www.businesswire.com/news/home/20200914005428/en/

Investors
Chris Stevo
Head of Investor Relations
(857) 338-9309

Media
Megan Goulart
Executive Director, Corporate Communications
(857) 338-8634

Source: Alexion Pharmaceuticals